It entered phase 1 over three years ago. If that tells us anything.
<<I think the PSMA ADC is interesting and I don't think of that as middling.<<
I guess we've all forgotten about Millennium's MLN2704, the PSMA-targeting ADC (from IMGN) which was in the clinic a decade ago and never got anywhere.